相关实验视频

Updated: May 6, 2026

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

在炎症性肠病中实施基于价值观的医疗保健 - - 一篇综述文章

Patrick Hilley^1,2,3, Simone Chin^1,2, Darren Wong^1,2

¹Department of Gastroenterology, The Austin Hospital, Melbourne, Australia.

Journal of Crohn's & colitis

|September 19, 2025

概括

需要创新的护理模式来管理炎症性肠病 (IBD). 基于价值的医疗保健 (VBHC) 优先考虑患者的结果和成本效益,提供了一种有前途的方法来改善IBD护理.

科学领域:

医疗保健服务研究医疗服务研究
胃肠病学胃肠病学
基于价值的医疗保健

背景情况:

全球炎症性肠病 (IBD) 的流行率和管理成本不断上升,需要改进护理模式.
传统的服务费模式不足以解决IBD患者的综合性患者旅程.
对于IBD患者来说,急需创新的医疗保健提供策略.

研究的目的:

在IBD护理中对以价值观为基础的医疗保健 (VBHC) 导向的方法进行全面的范围审查.
评估VBHC在IBD中的价值证明,包括临床结果,患者报告的结果 (PRO),成本和医疗保健利用率 (HCU).
确定促进因素,障碍,以及在IBD中实施VBHC模型的理想组成.

主要方法:

对现有文献进行全面的范围审查.
对VBHC在IBD护理中的实施进行分析.
评估价值指标,包括临床结果,PRO,成本和HCU.

主要成果:

VBHC模型旨在通过优先考虑以患者为中心的结果和成本效益来提供优质的护理.
该审查审查了VBHC方法如何影响IBD的临床结果,PRO,直接/间接成本和HCU.
确定了IBD中VBHC实施的关键推动因素和障碍.

结论:

VBHC提供了一个优化IBD护理的框架,通过专注于患者价值的结果和经济效率.
了解实施的推动因素和障碍,对于在IBD中成功采用VBHC至关重要.
IBD VBHC 模型的理想组成需要进一步的定义,以有效地展示价值主张.

更多相关视频

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease

Published on: September 20, 2018

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

相关概念视频

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Inflammatory Bowel Disease V: Surgical Management

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

Inflammatory Bowel Disease I: Introduction

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...